Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2024-01-18 00:00:00 ET · period of report 2024-01-18 · accession 0001415889-24-001537 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-18 | 2024-01-18 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $218.72 | -6,000 | 41.2K | -13% | -$1.31M |
| D | 2024-01-18 | 2024-01-18 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.6K | +16% | +$706.6K |
| D | 2024-01-18 | 2024-01-18 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -6,000 | 78.0K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-18 | S | D | 200 | $222.60 | 36,599 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $222.465 to $222.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2024-01-18 | S | D | 200 | $221.02 | 36,799 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $220.625 to $221.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2024-01-18 | S | D | 1,899 | $219.30 | 36,999 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $219.02 to $219.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2024-01-18 | S | D | 2,299 | $218.42 | 38,898 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $218.02 to $219.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2024-01-18 | M | A | 6,000 | $117.76 | 42,599 | D | — | — | |
| 6 | Common | Common Stock | 2024-01-18 | S | D | 1,402 | $217.55 | 41,197 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $216.99 to $217.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Derivative | Stock Options | 2024-01-18 | M | D | 6,000 | $0.00 | 78,000 | D | $117.76 · 2021-03-15 to 2027-03-15 | 6,000 Common Stock |